Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

NCT06893861 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT06893861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06893861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Recruiting
Start date
July 6, 2023
Completion date
July 31, 2025
Enrollment
3,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma (ec)